MediciNova, Inc.
MNOV
$1.51
$0.042.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.40% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.40% | -- | |||
| Cost of Revenue | -0.86% | -- | |||
| Gross Profit | -56.28% | -- | |||
| SG&A Expenses | 25.71% | 5.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.34% | 16.84% | |||
| Operating Income | 6.27% | -12.63% | |||
| Income Before Tax | 7.03% | -14.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.03% | -14.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.03% | -14.56% | |||
| EBIT | 6.27% | -12.63% | |||
| EBITDA | 6.28% | -12.66% | |||
| EPS Basic | 7.03% | -14.55% | |||
| Normalized Basic EPS | 6.94% | -14.52% | |||
| EPS Diluted | 7.03% | -11.50% | |||
| Normalized Diluted EPS | 6.94% | -14.52% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||